Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson's disease

Parkinsonism and Related Disorders

Volumn 16, Issue 10, 2010, Pages 686-687

  Nishioka, Kenya ^a   Vilariño Güell, Carles ^a   Cobb, Stephanie A ^a   Kachergus, Jennifer M ^a   Ross, Owen A ^a   Hentati, Emna ^a   Hentati, Faycal ^b   Farrer, Matthew J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Institut National de Neurologie Tunisia   (Tunisia)

Author keywords

Genetics; Mutation; NDUFV2; Parkinson disease

Indexed keywords

ARGININE; LYSINE; NDUFV2 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE UBIQUINONE FLAVOPROTEIN 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARAB; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ESSENTIAL TREMOR; ETHNIC DIFFERENCE; FEMALE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MALE; PARKINSON DISEASE; PARKINSONISM; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SEGREGATION ANALYSIS; SEQUENCE ANALYSIS;

AFRICA, NORTHERN; AGE OF ONSET; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; DNA; ELECTRON TRANSPORT COMPLEX I; FEMALE; GENE FREQUENCY; GENETIC VARIATION; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NADH DEHYDROGENASE; PARKINSON DISEASE; PEDIGREE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78649733457     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.09.007     Document Type: Article

References (13)

1. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nature Reviews 2006 Apr, 7(4):306-318.
2. Hulihan M.M., Ishihara-Paul L., Kachergus J., Warren L., Amouri R., Elango R., et al. LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurology 2008 Jul, 7(7):591-594.
3. Ishihara-Paul L., Hulihan M.M., Kachergus J., Upmanyu R., Warren L., Amouri R., et al. PINK1 mutations and parkinsonism. Neurology 2008 Sep 16, 71(12):896-902.
4. Nishioka K., Kefi M., Jasinska-Myga B., Wider C., Vilarino-Guell C., Ross O.A., et al. A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson disease. Journal of Neurology, Neurosurgery, and Psychiatry 2010 Apr, 81(4):391-395.
5. Hattori N., Yoshino H., Tanaka M., Suzuki H., Mizuno Y. Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. Genomics 1998 Apr 1, 49(1):52-58.
6. Washizuka S., Kakiuchi C., Mori K., Kunugi H., Tajima O., Akiyama T., et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2003 Jul 1, 120B(1):72-78.
7. Washizuka S., Kametani M., Sasaki T., Tochigi M., Umekage T., Kohda K., et al. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006 Apr 5, 141B(3):301-304.
8. Mizuta I., Tsunoda T., Satake W., Nakabayashi Y., Watanabe M., Takeda A., et al. Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease. Human Genetics 2008 Aug, 124(1):89-94.
9. Swerdlow R.H., Weaver B., Grawey A., Wenger C., Freed E., Worrall B.B. Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease. Journal of the Neurological Sciences 2006 Sep 25, 247(2):224-230.
10. Henchcliffe C., Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature Clinical Practice 2008 Nov, 4(11):600-609.
11. Ishihara L., Gibson R.A., Warren L., Amouri R., Lyons K., Wielinski C., et al. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Movement Disorders 2007 Jan, 22(1):55-61.
12. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992 Jun, 42(6):1142-1146.
13. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997 Jun, 276(5321):2045-2047.